| PRMT2 |
PRMT2, HMT1, HRMT1L1: Protein arginine N-methyltransferase 2 |
FYN |
IPI00640091 |
0.255 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
KIR3DL2 |
KIR3DL2, CD158K, NKAT4: Killer cell immunoglobulin-like receptor 3DL2 precursor |
0.255 |
Evidence |
|
| KARS |
KARS, KIAA0070: Lysyl-tRNA synthetase |
FUBP1 |
IPI00375441 |
0.255 |
Evidence |
|
| HMGN4 |
HMGN4, HMG17L3, NHC: High mobility group nucleosome-binding domain-containing pr |
TAOK3 |
TAOK3, DPK, JIK, KDS, MAP3K18: Serine/threonine-protein kinase TAO3 |
0.255 |
Evidence |
|
| PSMA1 |
PSMA1, PROS30, PSC2: Proteasome subunit alpha type-1 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
0.255 |
Evidence |
|
| F9 |
F9: Coagulation factor IX precursor |
HABP2 |
HABP2, HGFAL, PHBP: Hyaluronan-binding protein 2 precursor |
0.255 |
Evidence |
|
| SNRPD2 |
SNRPD2, SNRPD1: Small nuclear ribonucleoprotein Sm D2 |
GNB2L1 |
Lung cancer oncogene 7 |
0.255 |
Evidence |
|
| FCGR1A |
FCGR1A, FCG1, FCGR1, IGFR1: High affinity immunoglobulin gamma Fc receptor I pre |
CD302 |
CD302, CLEC13A, DCL1, KIAA0022: CD302 antigen precursor |
0.255 |
Evidence |
|
| DYRK2 |
DYRK2: Dual specificity tyrosine-phosphorylation-regulated kinase 2 |
JAK1 |
|
0.255 |
Evidence |
|
| NCR3 |
NCR3, 1C7, LY117: Natural cytotoxicity triggering receptor 3 precursor |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.255 |
Evidence |
|
| HLA-DQA1 |
HLA-DQA1: HLA class II histocompatibility antigen, DQ(5) alpha chain precursor |
CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
0.255 |
Evidence |
|
| SFRS3 |
SFRS3, SRP20: Splicing factor, arginine/serine-rich 3 |
RBM14 |
RBM14, SIP: RNA-binding protein 14 |
0.255 |
Evidence |
|
| NID1 |
NID1, NID: Nidogen-1 precursor |
MFAP5 |
MFAP5, MAGP2: Microfibrillar-associated protein 5 precursor |
0.255 |
Evidence |
|
| CD93 |
CD93, C1QR1, MXRA4: Complement component C1q receptor precursor |
LILRB2 |
IPI00303952 |
0.255 |
Evidence |
|
| DHX15 |
DHX15, DBP1, DDX15: Putative pre-mRNA-splicing factor ATP-dependent RNA helicase |
LSM6 |
LSM6: U6 snRNA-associated Sm-like protein LSm6 |
0.255 |
Evidence |
|
| CTRL |
PSMB10, MECL1: Proteasome subunit beta type-10 precursor |
STK10 |
STK10: Uncharacterized protein STK10 |
0.255 |
Evidence |
|
| S100A8 |
S100A8, CAGA, CFAG, MRP8: Protein S100-A8 |
S100A12 |
S100A12: Protein S100-A12 |
0.255 |
Evidence |
|
| EFEMP1 |
EFEMP1, FBLN3, FBNL: EGF-containing fibulin-like extracellular matrix protein 1 |
FSTL1 |
FSTL1, FRP: Follistatin-related protein 1 precursor |
0.255 |
Evidence |
|
| CD53 |
CD53, MOX44, TSPAN25: Leukocyte surface antigen CD53 |
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
0.255 |
Evidence |
|
| SCYE1 |
SCYE1, EMAP2: Multisynthetase complex auxiliary component p43 [Contains: Endothe |
FUBP1 |
IPI00375441 |
0.255 |
Evidence |
|
| LILRA1 |
LIR6, LILRA1: Leukocyte immunoglobulin-like receptor subfamily A member 1 precur |
LILRA3 |
LILRA3, ILT6, LIR4: Leukocyte immunoglobulin-like receptor subfamily A member 3 |
0.255 |
Evidence |
|
| MMP14 |
MMP14: Matrix metalloproteinase-14 precursor |
EFEMP1 |
EFEMP1, FBLN3, FBNL: EGF-containing fibulin-like extracellular matrix protein 1 |
0.255 |
Evidence |
|
| KRT16 |
KRT16, KRT16A: Keratin, type I cytoskeletal 16 |
EVPL |
EVPL: Envoplakin |
0.255 |
Evidence |
|
| OPCML |
OPCML, OBCAM: Opioid-binding protein/cell adhesion molecule precursor |
CDH10 |
CDH10: Cadherin-10 precursor |
0.255 |
Evidence |
|
| BTN3A3 |
BTN3A3, BTF3: Butyrophilin subfamily 3 member A3 precursor |
SIGIRR |
SIGIRR, UNQ301/PRO342: Single Ig IL-1-related receptor |
0.255 |
Evidence |
|
- 
- 
-